IDEXX LABORATORIES INC (IDXX)       400.1  -11.26 (-2.74%)

400.1  -11.26 (-2.74%)

US45168D1046 - Common Stock - After market: 400.1 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 489.22. This target is 22.27% above the current price.
IDXX was analyzed by 18 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about IDXX.
In the previous month the buy percentage consensus was at a similar level.
IDXX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 400.10383.80479.40489.22611.10 - -4.07% 19.82% 22.27% 52.74%

Up and Down Grades

Date Firm Action Rating
2022-11-15 Morgan Stanley Maintains Overweight
2022-11-02 Atlantic Equities Maintains Overweight
2022-10-17 JP Morgan Maintains Overweight
2022-08-05 Barclays Maintains Overweight
2022-08-04 Morgan Stanley Maintains Overweight
2022-08-03 Atlantic Equities Maintains Overweight
2022-07-26 Piper Sandler Maintains Overweight
2022-07-25 Stifel Downgrade Buy -> Hold
2022-07-21 Goldman Sachs Upgrade Neutral -> Buy
2022-07-12 Piper Sandler Initiate Overweight
2022-06-24 Stifel Maintains Buy
2022-05-19 Goldman Sachs Maintains Neutral
2022-05-05 B of A Securities Downgrade Buy -> Neutral
2022-05-05 Morgan Stanley Maintains Overweight
2022-02-08 Atlantic Equities Initiate Overweight
2021-11-18 Morgan Stanley Initiate Overweight
2021-08-13 Credit Suisse Maintains Outperform
2021-08-03 Goldman Sachs Maintains Neutral
2021-08-02 Barclays Maintains Overweight
2021-07-12 Guggenheim Downgrade Buy -> Neutral
2021-02-17 Barclays Initiate Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA